Advanced Medical Optics Announces Release Date for 2002 Third Quarter Results.Business Editors & Health/Medical Writers SANTA ANA, Calif.--(BUSINESS WIRE)--Oct. 14, 2002 Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. , Inc. (NYSE NYSE See: New York Stock Exchange :AVO a·vo n. pl. a·vos See Table at currency. [Portuguese, shortened from oitavo, eighth, from Latin oct ), a global leader in ophthalmic surgical devices and contact lens contact lens, thin plastic lens worn between the eye and eyelid that may be used instead of eyeglasses. Actors, models, and others wear them for appearance, and athletes use them for safety and convenience. care products, today announced it will report third quarter financial results before market open on Wednesday, November 6, 2002. James V. Mazzo, AMO's President and Chief Executive Officer, and Richard A. Meier, Corporate Vice President and Chief Financial Officer, will host a live webcast to discuss third quarter results on November 6, 2002, at 1:00 p.m. EST. To participate, please visit AMO's investor relations site at http://www.amo-inc.com. It is AMO's policy to comply fully with Regulation FD. Therefore, AMO AMO - America's Multimedia Online intends to utilize this webcast to discuss financially oriented goals and objectives and to disclose material Company and industry-based topics in an open manner. The Company does not plan to report or comment on its progress during the quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to the Company. During a quarter, the Company's commentary will be limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial. AMO will make no comments with respect to market rumors or speculation. About Advanced Medical Optics Advanced Medical Optics, Inc. (AMO) is a global leader in the development, manufacturing and marketing of medical devices for the eye and contact lens care products. The Company focuses on developing a broad suite of innovative technologies and devices to address a wide range of eye disorders. Products in the ophthalmic surgical line include foldable intraocular lenses, phacoemulsification phacoemulsification /phaco·emul·si·fi·ca·tion/ (-e-mul?si-fi-ka´shun) a method of cataract extraction in which the lens is fragmented by ultrasonic vibrations and simultaneously irrigated and aspirated. systems, viscoelastics and related products used in cataract surgery and microkeratomes used in LASIK LASIK laser-assisted in-situ keratomileusis. LA·SIK n. Eye surgery in which the surface of the cornea is reshaped using a laser, performed to correct certain refractive disorders such as myopia. procedures for refractive error correction. Among the well-known ophthalmic surgical product brands the company owns or has the rights to are Phacoflex(R), Clariflex(R), Array(R) and Sensar(R) foldable intraocular lenses, the Sovereign(R) phacoemulsification system and the Amadeus(R) microkeratome. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the well-known contact lens care product brands the company possesses are Complete(R), Complete(R) Blink-N-Clean(R), ConseptF(R), Consept 1 Step(R), Oxysept 1 Step(R), Ultracare(R), Ultrazyme(R) and Total Care(R). Amadeus is a licensed product of, and a trademark of, SIS, Ltd. Advanced Medical Optics, Inc. is based in Orange County, California Orange County is a county in Southern California, United States. Its county seat is Santa Ana. According to the 2000 Census, its population was 2,846,289, making it the second most populous county in the state of California, and the fifth most populous in the United States. , and employs approximately 2,000 worldwide. The company has operations in about 20 countries and markets products in approximately 60 countries. For more information, visit the company's web site at www.amo-inc.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion